Amino Acid Metabolism Practice Questions

Q: Which of the following statements about Maple Syrup Urine Disease (MSUD) is true?

Deficiency of branched chain amino acid enzymes. ***Deficiency of branched chain amino acid enzymes*** - MSUD is caused by a deficiency in the **branched-chain alpha-keto acid dehydrogenase complex (BCKDC)**, an enzyme responsible for metabolizing **leucine, isoleucine, and valine**. - This enzyme deficiency leads to the accumulation of these **branched-chain amino acids (BCAAs)** and their corresponding branched-chain alpha-keto acids in the body. *Asymptomatic* - MSUD is a severe metabolic disorder that is **not asymptomatic**; it typically presents with distinct neurological and metabolic symptoms shortly after birth. - Clinical manifestations can include **poor feeding, lethargy, seizures**, and a characteristic **maple syrup odor** in urine and earwax. *FeCl3 turns navy blue* - The **ferric chloride test (FeCl3 test)** in MSUD typically yields a **green-gray or dark-green color** when testing for the accumulation of alpha-keto acids (specifically alpha-ketoisocaproic acid). - A **navy blue color** with FeCl3 is more characteristic of **alkaptonuria** due to the presence of homogentisic acid. *Hyperaminoaciduria of aromatic amino acids* - MSUD is characterized by the accumulation and excretion of **branched-chain amino acids (leucine, isoleucine, valine)** and their corresponding keto acids. - **Hyperaminoaciduria of aromatic amino acids** (e.g., phenylalanine, tyrosine, tryptophan) is seen in other conditions like **phenylketonuria (PKU)**, not MSUD.

Q: Which of the following conditions is primarily treated with Vitamin B6?

Homocystinuria. ***Homocystinuria*** - The most common form of **homocystinuria** is caused by **cystathionine β-synthase (CBS) deficiency**, which requires **pyridoxal phosphate (Vitamin B6)** as a cofactor. - Approximately **50% of patients** with CBS deficiency are **B6-responsive**, making **high-dose Vitamin B6 (100-500 mg/day)** a **first-line primary treatment** for these cases. - This is a **clinically significant condition** that requires treatment, manifesting with features like **ectopia lentis, marfanoid habitus, intellectual disability, and thromboembolism**. - B6 supplementation enhances residual CBS enzyme activity and reduces plasma homocysteine levels. *Cystathionuria* - Caused by **cystathionine γ-lyase deficiency**, which also uses **Vitamin B6** as a cofactor. - This is generally a **benign, asymptomatic condition** that does **NOT require treatment**. - While B6 can reduce cystathionine accumulation, it is **not a primary treatment indication** because the condition is clinically insignificant. *Xanthurenic aciduria* - Caused by **kynureninase deficiency** in the **tryptophan metabolism pathway**, which requires **pyridoxal phosphate**. - This is a **rare and usually benign condition** that does not typically require treatment. - Not a primary indication for B6 therapy. *None of the options* - Incorrect, as **Homocystinuria** (CBS deficiency) is a **primary indication** for high-dose Vitamin B6 therapy in B6-responsive patients.

Q: Which amino acids accumulate in maple syrup urine disease?

All branched-chain amino acids. ***All branched-chain amino acids*** - Maple syrup urine disease (MSUD) is characterized by a deficiency in the **branched-chain alpha-keto acid dehydrogenase complex**, which is responsible for the breakdown of branched-chain amino acids (BCAAs). - This deficiency leads to the accumulation of **leucine, isoleucine, and valine**, along with their corresponding alpha-keto acids, in the blood and urine. - The distinctive **maple syrup odor** in the urine is caused by the accumulation of branched-chain keto acids derived from all three BCAAs. *Leucine* - While leucine is one of the BCAAs that accumulates in MSUD, it is not the *only* amino acid involved. - The accumulation of **leucine** is particularly associated with the severe neurological symptoms seen in MSUD, as it is the most neurotoxic of the three BCAAs. *Valine* - Valine is another BCAA that accumulates due to the metabolic block in MSUD. - However, the disease involves the accumulation of all three BCAAs, not just valine in isolation. *Isoleucine* - Isoleucine is the third BCAA that accumulates in MSUD due to the defective enzyme. - Like leucine and valine, isoleucine and its corresponding keto acid accumulate in blood and urine when the branched-chain alpha-keto acid dehydrogenase complex is deficient.

Q: Serotonin is derived from -

Tryptophan. ***Tryptophan*** - **Serotonin**, also known as 5-hydroxytryptamine (5-HT), is synthesized from the essential amino acid **tryptophan** through a two-step enzymatic pathway. - Tryptophan is first hydroxylated by tryptophan hydroxylase to 5-hydroxytryptophan (5-HTP), which is then decarboxylated by L-amino acid decarboxylase to form serotonin. *Tyrosine* - **Tyrosine** is a precursor for the synthesis of **catecholamines** (dopamine, norepinephrine, and epinephrine) and thyroid hormones. - It is not involved in the synthesis pathway for serotonin. *Phenylalanine* - **Phenylalanine** is an essential amino acid that is hydroxylated to form **tyrosine**. - Therefore, it is indirectly involved in catecholamine synthesis but not in serotonin synthesis. *Methionine* - **Methionine** is an essential amino acid primarily known for its role in protein synthesis and as a precursor for **S-adenosylmethionine (SAM)**, a methyl group donor in many biological reactions. - It does not serve as a direct precursor for serotonin.

Q: What is the primary enzymatic source of ammonia production in urine?

Glutaminase. ***Glutaminase*** - This enzyme catalyzes the **hydrolysis of glutamine** located predominantly in the cells of the **renal tubules**, producing **ammonia** (NH3) and glutamate. - This process is crucial for **acid-base balance**, as the ammonia can bind with excess hydrogen ions to form ammonium (NH4+), which is then excreted in the urine. *Urease* - This enzyme breaks down **urea into ammonia and carbon dioxide**, primarily produced by **bacteria**, not human renal cells, and contributes to ammonia in urine in cases of **urinary tract infections**. - While it produces ammonia, it is not the primary enzymatic source within the healthy human kidney for **acid-base regulation**. *Glutamate dehydrogenase* - This enzyme converts **glutamate into alpha-ketoglutarate and ammonia**, but its contribution to urinary ammonia production is secondary to glutaminase in the kidney. - Its primary role is in **oxidative deamination** and the interconversion of glutamate and alpha-ketoglutarate, acting in both mitochondrial and cytosolic compartments. *Arginase* - This enzyme is involved in the **urea cycle**, converting **arginine into urea and ornithine** in the liver. - While it is important for the detoxification of ammonia by converting it into urea for excretion, it **does not produce ammonia** in the kidney for urinary excretion.

Q: Catecholamines are synthesized from?

Tyrosine. ***Tyrosine*** - **Tyrosine** is the direct precursor amino acid for the synthesis of all **catecholamines**, including **dopamine**, **norepinephrine**, and **epinephrine**. - The synthesis pathway begins with the conversion of tyrosine to **L-DOPA** by tyrosine hydroxylase, followed by subsequent enzymatic steps. *Methionine* - **Methionine** is an essential amino acid primarily involved in **protein synthesis** and as a precursor for S-adenosylmethionine (SAM), a key methyl donor in various metabolic reactions. - It is not a direct precursor for the synthesis of **catecholamines**. *Histidine* - **Histidine** is the precursor for the synthesis of **histamine**, a neurotransmitter and inflammatory mediator. - It is not involved in the biosynthesis pathway of **catecholamines**. *Tryptophan* - **Tryptophan** is the precursor for the synthesis of **serotonin** and **melatonin**, important neurotransmitters and hormones. - It does not play a role in the synthesis of **catecholamines**.

Q: Which defect in the urea cycle is an X-linked disease?

Ornithine transcarbamylase. ***Ornithine transcarbamylase*** - **Ornithine transcarbamylase (OTC) deficiency** is the only **X-linked recessive** disorder among the urea cycle defects. - Males are usually more severely affected, while females can be symptomatic carriers. *Carbamoyl phosphate synthetase I* - **Carbamoyl phosphate synthetase I (CPS1) deficiency** is an **autosomal recessive** disorder. - It is one of the more severe urea cycle defects, leading to profound hyperammonemia. *Arginase* - **Arginase deficiency** (hyperargininemia) is an **autosomal recessive** disorder. - It typically presents with a distinct neurological phenotype, including spasticity and developmental delay. *Argininosuccinate synthase* - **Argininosuccinate synthase deficiency**, also known as **Citrullinemia type I**, is an **autosomal recessive** disorder. - It leads to the accumulation of **citrulline** and **ammonia** in the blood.

Q: Sweaty feet odor in urine is seen in which condition?

Isovaleric acidemia. ***Isovaleric acidemia*** - This condition is characterized by a distinctive "sweaty feet" odor in body fluids, including urine, due to the accumulation of **isovaleric acid**. - It results from a deficiency in the enzyme **isovaleryl-CoA dehydrogenase**, which is crucial for leucine metabolism. *Phenylketonuria* - Patients with **phenylketonuria (PKU)** typically have a "mousy" or "musty" odor in their urine, not a sweaty feet smell. - This is due to the accumulation of **phenylalanine** and its metabolites. *Maple syrup urine disease* - This metabolic disorder is named for the characteristic sweet, maple syrup-like odor of the urine, which is distinctly different from a sweaty feet odor. - It is caused by a defect in the metabolism of **branched-chain amino acids (leucine, isoleucine, and valine)**. *Alkaptonuria* - This condition is known for urine that turns **dark brown or black** upon standing or when exposed to air, due to the oxidation of **homogentisic acid**. - It does not produce a sweaty feet odor.

Q: In type IA Maple Syrup Urine Disease, which gene mutation is responsible?

BCKDHA. ***BCKDHA*** - **Maple Syrup Urine Disease (MSUD)** type IA is caused by a mutation in the **BCKDHA gene**, which codes for the E1α subunit of the **branched-chain α-keto acid dehydrogenase (BCKD) complex**. - This **enzyme complex** is crucial for the metabolism of **branched-chain amino acids (BCAAs)**: leucine, isoleucine, and valine. *BCKDHB* - The **BCKDHB gene** codes for the E1β subunit of the **BCKD complex**. - Mutations in **BCKDHB** are associated with **type IB MSUD**, not type IA. *DBT* - The **DBT gene** codes for the E2 subunit (dihydrolipoyl transacylase) of the **BCKD complex**. - Mutations in **DBT** are responsible for **type II MSUD**. *DLD* - The **DLD gene** codes for the E3 subunit (dihydrolipoyl dehydrogenase), which is a component shared by several **α-keto acid dehydrogenase complexes**. - Mutations in the **DLD gene** lead to **type III MSUD** and other pyruvate dehydrogenase complex deficiencies, rather than type IA.

Q: Which of the following amino acids is not involved in the production of creatine?

Alanine. ***Alanine*** - **Alanine** is not directly involved as a precursor for **creatine synthesis**. It can be converted to pyruvate and enter the gluconeogenic pathway. - The primary amino acids involved in **creatine synthesis** are arginine, glycine, and methionine. *Glycine* - **Glycine** is a direct precursor for creatine, reacting with arginine in the first step of its synthesis to form **guanidinoacetate**. - This reaction is catalyzed by **arginine:glycine amidinotransferase (AGAT)**. *Methionine* - **Methionine**, in the form of **S-adenosylmethionine (SAM)**, acts as the methyl donor in the second step of creatine synthesis. - It methylates guanidinoacetate to form **creatine**, a reaction catalyzed by **guanidinoacetate methyltransferase (GAMT)**. *Arginine* - **Arginine** donates its guanidino group to glycine, forming **guanidinoacetate**, the initial intermediate in creatine synthesis. - This is the first committed step in the **creatine biosynthesis pathway**.

Question 1

Which of the following statements about Maple Syrup Urine Disease (MSUD) is true?

Accepted Answer

Deficiency of branched chain amino acid enzymes

Answer

FeCl3 turns navy blue

Answer

Asymptomatic

Answer

Hyperaminoaciduria of aromatic amino acids

Question 2

Which of the following conditions is primarily treated with Vitamin B6?

Accepted Answer

Homocystinuria

Answer

Cystathionuria

Answer

None of the options

Answer

Xanthourenic aciduria

Question 3

Which amino acids accumulate in maple syrup urine disease?

Accepted Answer

All branched-chain amino acids

Answer

Valine

Answer

Leucine

Answer

Isoleucine

Question 4

Serotonin is derived from -

Accepted Answer

Tryptophan

Answer

Tyrosine

Answer

Phenylalanine

Answer

Methionine

Question 5

What is the primary enzymatic source of ammonia production in urine?

Accepted Answer

Glutaminase

Answer

Urease

Answer

Glutamate dehydrogenase

Answer

Arginase

Question 6

Catecholamines are synthesized from?

Accepted Answer

Tyrosine

Answer

Histidine

Answer

Methionine

Answer

Tryptophan

Question 7

Which defect in the urea cycle is an X-linked disease?

Accepted Answer

Ornithine transcarbamylase

Answer

Arginase

Answer

Argininosuccinate synthase

Answer

Carbamoyl phosphate synthetase I

Question 8

Sweaty feet odor in urine is seen in which condition?

Accepted Answer

Isovaleric acidemia

Answer

Phenylketonuria

Answer

Alkaptonuria

Answer

Maple syrup urine disease

Question 9

In type IA Maple Syrup Urine Disease, which gene mutation is responsible?

Accepted Answer

BCKDHA

Answer

BCKDHB

Answer

DBT

Answer

DLD

Question 10

Which of the following amino acids is not involved in the production of creatine?

Accepted Answer

Alanine

Answer

Glycine

Answer

Methionine

Answer

Arginine

Amino Acid Metabolism — MCQs

Amino Acid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?